IHS FormWeb
Approved Formulary
Search by name
Search by class
Show Therapeutic Classes
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Restricted Medications
Renal Adjustment Policy
Therapeutic Interchange Policy
Hazard.Drug Handling(USP 800)
Hazardous Waste
Chemotherapy
IV to PO Conversion Policy
Black Box Warnings
Look-Alike/Sound-Alike
REMS
Staff Telephone Numbers
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
IHS FormWeb
Approved Formulary
Search by name
Additional search options
Search by class
Show Therapeutic Classes
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Restricted Medications
Renal Adjustment Policy
Therapeutic Interchange Policy
Hazard.Drug Handling(USP 800)
Hazardous Waste
Chemotherapy
IV to PO Conversion Policy
Black Box Warnings
Look-Alike/Sound-Alike
REMS
Staff Telephone Numbers
Webpage Links
Search results for:
esterified estrogens-methylTESTOSTERone
esterified estrogens-methylTESTOSTERone
Restricted Medications
Non-Formulary / Not-stocked
Brand names:
Estratest H.S.
Form
Strength
TABLET, ORAL
0.625 mg / 1.25 mg
Display
Androgens
,
Estrogens
Class:
680800
,
681604
Medication comments:
USP <800> Hazardous Drug Assessment of Risk (AOR)
View all
Per policy, these drugs are exempt from USP <800> handling requirements under normal circumstances.
The following outlines must be followed.
generic (Brand) Route
[Packaging: Manufacturer ⇒ Dispense]
Activities
esterified estrogens and methylTESTOSTERone (Estratest HS)
PO
[Bulk ⇒ Packager]
0.625 mg/1.25 mg tablet
Stock @ IDBH? N
NIOSH Table 2
↑
Pharmacy:
Receiving / Storage / Preparation
Exposure Risk: low
• Handling/preparation PPE Requirements:
Single CX glove
Wash hands after handling
• Receiving from Distributor:
Standard
• Pharmacy Storage Area:
CSM
• Packaging/Reconstitution Location:
Repacking area
• Compounding (Non-Sterile/Sterile) Location:
n/a
• Omnicell Load:
Yes
Transport
• Transport (dose is placed inside a plastic sealable bag):
Standard
Nursing:
Storage / Administration
Exposure Risk: low
• Handling/administration PPE Requirements:
Single pair of CX approved gloves. Wash hands after handling
• Storage of Finished dose in Nursing Area/Procedural Area:
Omnicell
• Signage on Patient Door Required:
No
• Manipulation of Dosage Form:
Standard
• Special Manipulation for Administration:
n/a
Disposal / Spills
• Disposal of Drug Waste:
Full-
Rx Destroyer
, packaging- trash
• Disposol of Used PPE:
trash bin (inside plastic bag)
• Spill management:
n/a
Last updated:
Jun. 5, 2025
Hazard.Drug Handling(USP 800)
USP<800> Hazardous Drug / Assessment of Risk
Black Box Warnings
estrogen: Endometrial cancer; cardiovascular; dementia risk
UpToDate
FDA DailyMed Package Insert
MedLinePlus (Patient Information)
MSDS Online
UpToDate Lexidrug
The following outlines must be followed.
[Packaging: Manufacturer ⇒ Dispense]
[Bulk ⇒ Packager]
NIOSH Table 2↑
Receiving / Storage / Preparation
Wash hands after handling
Storage / Administration